These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

925 related items for PubMed ID: 15277226

  • 1. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
    Guo H, Albrecht S, Bourdeau M, Petzke T, Bergeron C, LeBlanc AC.
    Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
    [Abstract] [Full Text] [Related]

  • 2. Activation of caspase-6 in aging and mild cognitive impairment.
    Albrecht S, Bourdeau M, Bennett D, Mufson EJ, Bhattacharjee M, LeBlanc AC.
    Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160
    [Abstract] [Full Text] [Related]

  • 3. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain.
    Rohn TT, Rissman RA, Davis MC, Kim YE, Cotman CW, Head E.
    Neurobiol Dis; 2002 Nov; 11(2):341-54. PubMed ID: 12505426
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Memory performance is related to amyloid and tau pathology in the hippocampus.
    Reitz C, Honig L, Vonsattel JP, Tang MX, Mayeux R.
    J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):715-21. PubMed ID: 19258354
    [Abstract] [Full Text] [Related]

  • 7. Apolipoprotein E genotype in senile dementia with tangles differs from Alzheimer's disease.
    Tolnay M, Villoz N, Probst A, Miserez AR.
    Neuropathol Appl Neurobiol; 2003 Feb; 29(1):80-4. PubMed ID: 12581343
    [No Abstract] [Full Text] [Related]

  • 8. Caspase-6 activation in familial alzheimer disease brains carrying amyloid precursor protein or presenilin i or presenilin II mutations.
    Albrecht S, Bogdanovic N, Ghetti B, Winblad B, LeBlanc AC.
    J Neuropathol Exp Neurol; 2009 Dec; 68(12):1282-93. PubMed ID: 19915487
    [Abstract] [Full Text] [Related]

  • 9. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N, Fukatsu R, Tsuzuki K, Hayashi Y, Yoshida T, Fujii N, Koike T, Wakayama I, Yanagihara R, Garruto R, Amano N, Makita Z.
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [Abstract] [Full Text] [Related]

  • 10. 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease.
    Umahara T, Uchihara T, Tsuchiya K, Nakamura A, Iwamoto T, Ikeda K, Takasaki M.
    Acta Neuropathol; 2004 Oct; 108(4):279-86. PubMed ID: 15235803
    [Abstract] [Full Text] [Related]

  • 11. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
    Yilmazer-Hanke DM, Hanke J.
    Dement Geriatr Cogn Disord; 1999 Oct; 10(2):70-6. PubMed ID: 10026378
    [Abstract] [Full Text] [Related]

  • 12. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease.
    Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL.
    Proc Natl Acad Sci U S A; 2003 Aug 19; 100(17):10032-7. PubMed ID: 12888622
    [Abstract] [Full Text] [Related]

  • 13. Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert.
    Sassin I, Schultz C, Thal DR, Rüb U, Arai K, Braak E, Braak H.
    Acta Neuropathol; 2000 Sep 19; 100(3):259-69. PubMed ID: 10965795
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
    Mizukami K, Akatsu H, Abrahamson EE, Mi Z, Ikonomovic MD.
    Neuropathology; 2016 Apr 19; 36(2):135-45. PubMed ID: 26293308
    [Abstract] [Full Text] [Related]

  • 15. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG, Stein TD, Tai HC, Dols-Icardo O, Scotton TC, Barroeta-Espar I, Fernandez-Carballo L, de Munain EL, Perez J, Marquie M, Serrano-Pozo A, Frosch MP, Lowe V, Parisi JE, Petersen RC, Ikonomovic MD, López OL, Klunk W, Hyman BT, Gómez-Isla T.
    Brain; 2013 Aug 19; 136(Pt 8):2510-26. PubMed ID: 23824488
    [Abstract] [Full Text] [Related]

  • 16. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
    Serrano-Pozo A, William CM, Ferrer I, Uro-Coste E, Delisle MB, Maurage CA, Hock C, Nitsch RM, Masliah E, Growdon JH, Frosch MP, Hyman BT.
    Brain; 2010 May 19; 133(Pt 5):1312-27. PubMed ID: 20360050
    [Abstract] [Full Text] [Related]

  • 17. Direct determination of the proportion of intra- and extra-cellular neocortical neurofibrillary tangles in Alzheimer's disease.
    Vickers JC, Tan A, Dickson TC.
    Brain Res; 2003 May 02; 971(1):135-7. PubMed ID: 12691846
    [Abstract] [Full Text] [Related]

  • 18. Evolutional aspects of Alzheimer's disease pathogenesis.
    Braak H, Del Tredici K.
    J Alzheimers Dis; 2013 May 02; 33 Suppl 1():S155-61. PubMed ID: 22699850
    [Abstract] [Full Text] [Related]

  • 19. Alzheimer's disease: pathogenesis and prevention.
    Braak H, Del Tredici K.
    Alzheimers Dement; 2012 May 02; 8(3):227-33. PubMed ID: 22465174
    [Abstract] [Full Text] [Related]

  • 20. Brainstem tau pathology in Alzheimer's disease is characterized by increase of three repeat tau and independent of amyloid β.
    Uematsu M, Nakamura A, Ebashi M, Hirokawa K, Takahashi R, Uchihara T.
    Acta Neuropathol Commun; 2018 Jan 03; 6(1):1. PubMed ID: 29298724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.